Geneyx provides DNA and RNA data analysis and interpretation for whole genome sequencing (WGS), whole exome sequencing (WES), gene panels, and microarrays, enabling rapid transformation of raw genetic data into clinical reports. The platform enhances diagnostic accuracy and efficiency, aiming to eliminate undiagnosed diseases by increasing the diagnostic yield and reducing turnaround times for genetic testing.
Funding
$11.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The increasing volume and complexity of DNA and RNA sequencing data from WGS, WES, gene panels, and microarrays present a significant bottleneck in clinical diagnostics and research. Manual analysis and interpretation of this data are time-consuming, error-prone, and require specialized bioinformatics expertise, hindering the efficient translation of genetic information into actionable clinical insights.
Solution
Geneyx provides an AI-powered platform that automates the analysis and interpretation of DNA and RNA sequencing data, accelerating the generation of clinical reports and facilitating genomic and clinical cohort analysis. The platform streamlines the diagnostic process, enabling users to identify novel biomedical insights, improve diagnostic yields, and reduce turnaround times. By offering customizable workflows, a comprehensive annotation engine, and an intuitive variant browsing interface, Geneyx empowers clinicians and researchers to efficiently analyze and interpret complex genetic data, ultimately promoting a world with zero undiagnosed diseases.
Target Audience
Geneyx is designed for hospitals, commercial labs, and research institutions that perform genetic testing and analysis, including clinical geneticists, molecular biologists, and bioinformaticians.
Features
- AI-based analysis and interpretation of WGS, WES, gene panels, and microarray data
- Customizable protocols for whole genome sequencing, exome sequencing, and gene panels
- Comprehensive annotation engine supporting structural and copy number variations, as well as regulatory elements
- Rapid phenotype-driven interpretation using HPO terms and free search terms
- Advanced ACMG/ClinGen variant classification with automated annotations
- Integration of RNA sequencing data with DNA sequencing information for enhanced variant detection
- Automated Uniparental Disomy (UPD) analysis with UPD scores and inheritance categories
- Integrated pharmacogenomics (PGx) workflow with interpretations for CPIC level A/B genes
- NGS pipeline management and genetic data storage following HIPAA and GDPR guidelines